Advertisement
UK markets close in 4 hours 56 minutes
  • FTSE 100

    7,833.93
    -43.12 (-0.55%)
     
  • FTSE 250

    19,286.11
    -164.56 (-0.85%)
     
  • AIM

    741.37
    -3.92 (-0.53%)
     
  • GBP/EUR

    1.1673
    -0.0010 (-0.09%)
     
  • GBP/USD

    1.2448
    +0.0009 (+0.07%)
     
  • Bitcoin GBP

    51,961.02
    +2,419.18 (+4.88%)
     
  • CMC Crypto 200

    1,334.72
    +22.09 (+1.71%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CRUDE OIL

    82.50
    -0.23 (-0.28%)
     
  • GOLD FUTURES

    2,396.20
    -1.80 (-0.08%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,718.34
    -119.06 (-0.67%)
     
  • CAC 40

    7,996.59
    -26.67 (-0.33%)
     

Ultimovacs ASA: Mandatory notification of trade by primary insider

Ultimovacs ASA
Ultimovacs ASA

Oslo, 05 September 2022, Carlos de Sousa, Chief Executive Officer and primary insider in Ultimovacs ASA, has today bought 2,000 shares in the company at an average price of NOK 67.10 per share. Following this transaction, Carlos de Sousa and closely related parties hold 20,056 shares and 416,035 share options in Ultimovacs ASA.

This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities Trading Act.


Attachment